Literature DB >> 21049984

Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.

Shuqi Xie1, Abdolsamad Borazjani, M Jason Hatfield, Carol C Edwards, Philip M Potter, Matthew K Ross.   

Abstract

Carboxylesterases (CES) have important roles in pesticide and drug metabolism and contribute to the clearance of ester-containing xenobiotics in mammals. Tissues with the highest levels of CES expression are the liver and small intestine. In addition to xenobiotics, CES also harness their broad substrate specificity to hydrolyze endobiotics, such as cholesteryl esters and triacylglycerols. Here, we determined if two human CES isoforms, CES1 and CES2, hydrolyze the endocannabinoids 2-arachidonoylglycerol (2AG) and anandamide (AEA), and two prostaglandin glyceryl esters (PG-Gs), which are formed by COX-mediated oxygenation of 2AG. We show that recombinant CES1 and CES2 efficiently hydrolyze 2AG to arachidonic acid (AA) but not amide-containing AEA. Steady-state kinetic parameters for CES1- and CES2-mediated 2AG hydrolysis were, respectively, kcat, 59 and 43 min(-1); Km, 49 and 46 μM; and kcat/Km, 1.2 and 0.93 μM(-1) min(-1). kcat/Km values are comparable to published values for rat monoacylglycerol lipase (MAGL)-catalyzed 2AG hydrolysis. Furthermore, we show that CES1 and CES2 also efficiently hydrolyze PGE2-G and PGF2α-G. In addition, when cultured human THP1 macrophages were treated with exogenous 2AG or PG-G (10 μM, 1 h), significant quantities of AA or PGs were detected in the culture medium; however, the ability of macrophages to metabolize these compounds was inhibited (60-80%) following treatment with paraoxon, the toxic metabolite of the insecticide parathion. Incubation of THP1 cell lysates with small-molecule inhibitors targeting CES1 (thieno[3,2-e][1]benzothiophene-4,5-dione or JZL184) significantly reduced lipid glyceryl ester hydrolase activities (40-50% for 2AG and 80-95% for PG-Gs). Immunodepletion of CES1 also markedly reduced 2AG and PG-G hydrolase activities. These results suggested that CES1 is in part responsible for the hydrolysis of 2AG and PG-Gs in THP1 cells, although it did not rule out a role for other hydrolases, especially with regard to 2AG metabolism since a substantial portion of its hydrolysis was not inactivated by the inhibitors. An enzyme (Mr 31-32 kDa) of unknown function was detected by serine hydrolase activity profiling of THP1 cells and may be a candidate. Finally, the amounts of in situ generated 2AG and PG-Gs in macrophages were enhanced by treating the cells with bioactive metabolites of OP insecticides. Collectively, the results suggest that in addition to MAGL and fatty-acid amide hydrolase (FAAH), which have both been documented to terminate endocannabinoid signaling, CES may also have a role. Furthermore, since PG-Gs have been shown to possess biological activities in their own right, CES may represent an important enzyme class that regulates their in vivo levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21049984      PMCID: PMC4065498          DOI: 10.1021/tx1002194

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  52 in total

1.  Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism.

Authors:  Jonathan Z Long; Daniel K Nomura; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2009-07-31

Review 2.  Enzymatic pathways that regulate endocannabinoid signaling in the nervous system.

Authors:  Kay Ahn; Michele K McKinney; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2008-04-23       Impact factor: 60.622

3.  Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages.

Authors:  Li-sheng Jiang; Jun Pu; Zhi-hua Han; Liu-hua Hu; Ben He
Journal:  Cardiovasc Res       Date:  2008-12-11       Impact factor: 10.787

Review 4.  Pest toxicology: the primary mechanisms of pesticide action.

Authors:  John E Casida
Journal:  Chem Res Toxicol       Date:  2009-04       Impact factor: 3.739

Review 5.  The emerging role of the endocannabinoid system in cardiovascular disease.

Authors:  Pál Pacher; Sabine Steffens
Journal:  Semin Immunopathol       Date:  2009-04-09       Impact factor: 9.623

Review 6.  Endocannabinoids and the control of energy homeostasis.

Authors:  George Kunos; Douglas Osei-Hyiaman; Jie Liu; Gregorz Godlewski; Sándor Bátkai
Journal:  J Biol Chem       Date:  2008-08-11       Impact factor: 5.157

7.  Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages.

Authors:  Koichi Sugamura; Seigo Sugiyama; Toshimitsu Nozaki; Yasushi Matsuzawa; Yasuhiro Izumiya; Keishi Miyata; Masafumi Nakayama; Koichi Kaikita; Toru Obata; Motohiro Takeya; Hisao Ogawa
Journal:  Circulation       Date:  2008-12-22       Impact factor: 29.690

8.  Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice.

Authors:  Frédérique Dol-Gleizes; Réjane Paumelle; Virgile Visentin; Anne-Marie Marés; Perrine Desitter; Nathalie Hennuyer; Andries Gilde; Bart Staels; Paul Schaeffer; Françoise Bono
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-10-09       Impact factor: 8.311

9.  Activation of the endocannabinoid system by organophosphorus nerve agents.

Authors:  Daniel K Nomura; Jacqueline L Blankman; Gabriel M Simon; Kazutoshi Fujioka; Roger S Issa; Anna M Ward; Benjamin F Cravatt; John E Casida
Journal:  Nat Chem Biol       Date:  2008-04-27       Impact factor: 15.040

10.  Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.

Authors:  Jonathan Z Long; Weiwei Li; Lamont Booker; James J Burston; Steven G Kinsey; Joel E Schlosburg; Franciso J Pavón; Antonia M Serrano; Dana E Selley; Loren H Parsons; Aron H Lichtman; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2008-11-23       Impact factor: 15.040

View more
  37 in total

Review 1.  Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation.

Authors:  Daniel J Hermanson; Joyonna C Gamble-George; Lawrence J Marnett; Sachin Patel
Journal:  Trends Pharmacol Sci       Date:  2014-05-18       Impact factor: 14.819

Review 2.  Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling.

Authors:  Gernot F Grabner; Robert Zimmermann; Rudolf Schicho; Ulrike Taschler
Journal:  Pharmacol Ther       Date:  2017-02-14       Impact factor: 12.310

3.  (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2.

Authors:  Kelsey C Duggan; Daniel J Hermanson; Joel Musee; Jeffery J Prusakiewicz; Jami L Scheib; Bruce D Carter; Surajit Banerjee; J A Oates; Lawrence J Marnett
Journal:  Nat Chem Biol       Date:  2011-11       Impact factor: 15.040

4.  Inhibition of Endocannabinoid-Metabolizing Enzymes in Peripheral Tissues Following Developmental Chlorpyrifos Exposure in Rats.

Authors:  Robert W Buntyn; Navatha Alugubelly; Rachel L Hybart; Afzaal N Mohammed; Carole A Nail; Greta C Parker; Matthew K Ross; Russell L Carr
Journal:  Int J Toxicol       Date:  2017-08-18       Impact factor: 2.032

5.  Silencing carboxylesterase 1 in human THP-1 macrophages perturbs genes regulated by PPARγ/RXR and RAR/RXR: down-regulation of CYP27A1-LXRα signaling.

Authors:  Lee C Mangum; Xiang Hou; Abdolsamad Borazjani; Jung Hwa Lee; Matthew K Ross; J Allen Crow
Journal:  Biochem J       Date:  2018-02-09       Impact factor: 3.857

6.  Inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by chlorpyrifos oxon, paraoxon and methyl paraoxon.

Authors:  J Allen Crow; Victoria Bittles; Katye L Herring; Abdolsamad Borazjani; Philip M Potter; Matthew K Ross
Journal:  Toxicol Appl Pharmacol       Date:  2011-11-04       Impact factor: 4.219

7.  Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.

Authors:  Andrew J Kwilasz; Rehab A Abdullah; Justin L Poklis; Aron H Lichtman; Sidney S Negus
Journal:  Behav Pharmacol       Date:  2014-04       Impact factor: 2.293

8.  Cannabinoids as anticancer therapeutic agents.

Authors:  Olga Kovalchuk; Igor Kovalchuk
Journal:  Cell Cycle       Date:  2020-04-05       Impact factor: 4.534

9.  Exposure to p,p'-DDE Alters Macrophage Reactivity and Increases Macrophage Numbers in Adipose Stromal Vascular Fraction.

Authors:  Lauren H Mangum; John Allen Crow; John V Stokes; George E Howell; Matthew K Ross; Stephen B Pruett; Janice E Chambers
Journal:  Toxicol Sci       Date:  2016-01-08       Impact factor: 4.849

10.  The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.

Authors:  D M Kerr; B Harhen; B N Okine; L J Egan; D P Finn; M Roche
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.